KEAP1 and atherosclerosis: Zhang et al. [47] reported that hsa-miR-141-3p suppresses vascular smooth muscle cell growth and migration, mitigating atherosclerosis by targeting the Keap1/Nrf2/HO-1 signaling pathway.